Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Molecular Biology›Cell Survival
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Cell Survival

Molecular Biology · NLM MeSH · updated 2026-10-29 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 4 min read

The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (694 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Survival, Cell; Cell Viability; Cell Viabilities; Viabilities, Cell; Viability, Cell.

Where it fits in the MeSH classification

Broader topics
Cell Physiological Phenomena

Research landscape

PubMed indexes 237,115 records tagged with the MeSH heading “Cell Survival” (counts retrieved 2026-10-29). 40,659 of them (17.1%) were published from 2020 onward, and the busiest period so far is 2010-2019 with 102,219 records.

Reviews account for 8,750 records (3.7%) and meta-analyses for 60. Randomized controlled trials number 238 (0.1%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 44,290 records; 2000-2009: 49,947 records; 2010-2019: 102,219 records; 2020 onward: 40,659 records44,290through 199949,9472000-2009102,2192010-201940,6592020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 199944,290
2000-200949,947
2010-2019102,219
2020 onward40,659
Share of records by publication typeReviews: 3.7 percent; Meta-analyses: 0.0 percent; Randomized controlled trials: 0.1 percentReviews3.7% (8,750)Meta-analyses0.0% (60)Randomized controlled trials0.1% (238)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 237,115 PubMed records
TypeRecordsShare
Reviews8,7503.7%
Meta-analyses600.0%
Randomized controlled trials2380.1%

Method: PubMed query "Cell Survival"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-29.

Reading the evidence in molecular biology

Molecular biology establishes mechanisms through controlled experiments, often in simplified systems such as purified proteins, cultured cells or model organisms. Such work can show what is possible in a defined system, but whether a pathway matters in a whole organism or in human disease needs further evidence. Check the experimental system, whether findings were reproduced by independent groups, and whether the authors tested the mechanism directly or inferred it from correlation.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
mTORC1 regulates cell survival under glucose starvation through 4EBP1/2-mediated translational reprogramming of fatty acid metabolism
Levy T, Voeltzke K, Hruby L, Alasad K, Bas Z, Snaebjörnsson M, et al.
2024Research article
Design not recorded in structured metadata
44cc by
PMID 38744825 · DOI · PMC11094136
Mitochondrial-cytochrome c oxidase II promotes glutaminolysis to sustain tumor cell survival upon glucose deprivation
Yi Y, Wang G, Zhang W, Yu S, Fei J, An T, et al.
2025Research article
Design not recorded in structured metadata
34cc by
PMID 39747079 · DOI · PMC11695821
Curcumin Induces Autophagy-mediated Ferroptosis by Targeting the PI3K/AKT/mTOR Signaling Pathway in Gastric Cancer
Zheng X, Liu J, Hu W, Jiang B, Zhou X, Zhang M, et al.
2024Research article
Design not recorded in structured metadata
30cc by
PMID 39150386 · DOI · PMC11363205
Characterizing the molecular mechanisms underlying aluminium-induced disruptions in neuronal survival pathways
Sravya K, Rao A, Harshitha P, Parithathvi A, Dsouza HS
2026Review article
Design not recorded in structured metadata
0cc by
PMID 42658284 · DOI · PMC13522080

mTORC1 regulates cell survival under glucose starvation through 4EBP1/2-mediated translational reprogramming of fatty acid metabolism [1]

Research article Levy T, Voeltzke K, Hruby L, Alasad K, Bas Z, Snaebjörnsson M, et al. · · 2024 · cited 44 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Energetic stress compels cells to evolve adaptive mechanisms to adjust their metabolism.
Closing excerpt
Our data reveal that the mTORC1-4EBP1/2 axis provokes a metabolic switch essential for survival during glucose starvation which is exploited by transformed and tumor cells.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (162 words)

Energetic stress compels cells to evolve adaptive mechanisms to adjust their metabolism. Inhibition of mTOR kinase complex 1 (mTORC1) is essential for cell survival during glucose starvation. How mTORC1 controls cell viability during glucose starvation is not well understood. Here we show that the mTORC1 effectors eukaryotic initiation factor 4E binding proteins 1/2 (4EBP1/2) confer protection to mammalian cells and budding yeast under glucose starvation. Mechanistically, 4EBP1/2 promote NADPH homeostasis by preventing NADPH-consuming fatty acid synthesis via translational repression of Acetyl-CoA Carboxylase 1 (ACC1), thereby mitigating oxidative stress. This has important relevance for cancer, as oncogene-transformed cells and glioma cells exploit the 4EBP1/2 regulation of ACC1 expression and redox balance to combat energetic stress, thereby supporting transformation and tumorigenicity in vitro and in vivo. Clinically, high EIF4EBP1 expression is associated with poor outcomes in several cancer types. Our data reveal that the mTORC1-4EBP1/2 axis provokes a metabolic switch essential for survival during glucose starvation which is exploited by transformed and tumor cells.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 38744825 · DOI · PMC11094136

Mitochondrial-cytochrome c oxidase II promotes glutaminolysis to sustain tumor cell survival upon glucose deprivation [2]

Research article Yi Y, Wang G, Zhang W, Yu S, Fei J, An T, et al. · · 2025 · cited 34 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Glucose deprivation, a hallmark of the tumor microenvironment, compels tumor cells to seek alternative energy sources for survival and growth.
Closing excerpt
Together, these findings reveal a role for MT-CO2 in adapting to metabolic stress and highlight MT-CO2 as a putative therapeutic target for Ras-driven cancers.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (150 words)

Glucose deprivation, a hallmark of the tumor microenvironment, compels tumor cells to seek alternative energy sources for survival and growth. Here, we show that glucose deprivation upregulates the expression of mitochondrial-cytochrome c oxidase II (MT-CO2), a subunit essential for the respiratory chain complex IV, in facilitating glutaminolysis and sustaining tumor cell survival. Mechanistically, glucose deprivation activates Ras signaling to enhance MT-CO2 transcription and inhibits IGF2BP3, an RNA-binding protein, to stabilize MT-CO2 mRNA. Elevated MT-CO2 increases flavin adenosine dinucleotide (FAD) levels in activating lysine-specific demethylase 1 (LSD1) to epigenetically upregulate JUN transcription, consequently promoting glutaminase-1 (GLS1) and glutaminolysis for tumor cell survival. Furthermore, MT-CO2 is indispensable for oncogenic Ras-induced glutaminolysis and tumor growth, and elevated expression of MT-CO2 is associated with poor prognosis in lung cancer patients. Together, these findings reveal a role for MT-CO2 in adapting to metabolic stress and highlight MT-CO2 as a putative therapeutic target for Ras-driven cancers.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 39747079 · DOI · PMC11695821

Curcumin Induces Autophagy-mediated Ferroptosis by Targeting the PI3K/AKT/mTOR Signaling Pathway in Gastric Cancer [3]

Research article Zheng X, Liu J, Hu W, Jiang B, Zhou X, Zhang M, et al. · · 2024 · cited 30 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
As a very common malignancy of the digestive system, the incidence and mortality rates of gastric cancer (GC) are increasing year by year.
Closing excerpt
Curcumin suppresses GC development by inducing autophagy-mediated ferroptosis by inactivating the PI3K/AKT/mTOR signaling.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (235 words)

As a very common malignancy of the digestive system, the incidence and mortality rates of gastric cancer (GC) are increasing year by year. The critical role of ferroptosis in cancer development has been well-documented. The polyphenol compound curcumin shows prominent anti-tumor effects in multiple cancer types, including GC. However, whether curcumin participates in GC tumorigenesis by regulating ferroptosis remains unknown. Gastric cancer cells AGS and HGC-27 were treated with curcumin (0, 10, and 20 μM). Cell viability and death were evaluated through CCK-8 and LDH release assays. LC3B expression in cells was estimated through immunofluorescence staining. Intracellular ferrous iron (Fe2+), GSH, MDA, and lipid ROS levels were assessed by corresponding assay kits. The cellular levels of autophagy markers (ATG5, ATG7, Beclin 1, and LC3B), ferroptosis markers (ACSL4, SLC7A11, and GPX4), and phosphorylated (p)-PI3K, p-AKT, and p-mTOR were determined through western blotting. Curcumin attenuated cell viability but stimulated cell death in GC cells. Curcumin enhanced autophagy in GC cells, as demonstrated by the increased levels of ATG5, ATG7, Beclin 1, and LC3B. Besides, curcumin upregulated iron, MDA, GSH, and ACSL4 levels while downregulated lipid ROS, SLC7A11, and GPX4 levels, suggesting its stimulation on ferroptosis in GC cells. Curcumin decreased p-PI3K, p-AKT, and p-mTOR levels in cells. Importantly, the ferroptosis inhibitor ferrostatin-1 overturned the impacts of curcumin on GC cell viability, death, and ferroptosis. Curcumin suppresses GC development by inducing autophagy-mediated ferroptosis by inactivating the PI3K/AKT/mTOR signaling.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 39150386 · DOI · PMC11363205

Characterizing the molecular mechanisms underlying aluminium-induced disruptions in neuronal survival pathways [4]

Review article Sravya K, Rao A, Harshitha P, Parithathvi A, Dsouza HS · · 2026

Abstract reading summary — source excerpts
Opening excerpt
Aluminium, an omnipresent environmental pollutant, has been recognized for its neurotoxic effects, particularly its ability to promote neuronal death.
Closing excerpt
A thorough understanding of these changes provides a fundamental explanation of the role of aluminium toxicity in the etiology of neurodegenerative diseases and provides a foundation for treatment.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (147 words)

Aluminium, an omnipresent environmental pollutant, has been recognized for its neurotoxic effects, particularly its ability to promote neuronal death. More research evidence links aluminium exposure to death through molecular mechanisms. This review delves into the mechanisms underlying aluminium-induced neurotoxicity, including programmed cell death pathways such as apoptosis, necroptosis, autophagy, ferroptosis, and pyroptosis. Aluminium exposure leads to disruption of oxidative homeostasis and induction of endoplasmic reticulum stress, mitochondrial dysfunction and DNA damage, which in turn trigger different cell death pathways. Substantial changes in key signalling pathways, such as the IL-1β/JNK, PI3K/Akt/mTOR, Nrf2/Ho-1, System Xc-/GPX4, and NLRP3 inflammasome activation pathways, were observed. Overall, these intertwined pathways highlight aluminium as a potent modulator of neuronal survival pathways, driving neurodegeneration through multifactorial mechanisms. A thorough understanding of these changes provides a fundamental explanation of the role of aluminium toxicity in the etiology of neurodegenerative diseases and provides a foundation for treatment.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42658284 · DOI · PMC13522080

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article An overview of autophagy: morphology, mechanism, and regulation [5]
    Parzych KR, Klionsky DJ · Antioxid Redox Signal · 2014 · cited 1,988 times (Europe PMC)
  • Research article Mechanisms of cancer drug resistance [6]
    Gottesman MM · Annu Rev Med · 2002 · cited 1,902 times (Europe PMC)
  • Research article The Bcl-2 family: roles in cell survival and oncogenesis [7]
    Cory S, Huang DC, Adams JM · Oncogene · 2003 · cited 1,085 times (Europe PMC)
  • Research article p53 in survival, death and metabolic health: a lifeguard with a licence to kill [8]
    Kruiswijk F, Labuschagne CF, Vousden KH · Nat Rev Mol Cell Biol · 2015 · cited 884 times (Europe PMC)
  • Research article Autophagy and signaling: their role in cell survival and cell death [9]
    Codogno P, Meijer AJ · Cell Death Differ · 2005 · cited 851 times (Europe PMC)
  • Research article Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays [10]
    Rampersad SN · Sensors (Basel) · 2012 · cited 735 times (Europe PMC)

References

  1. Levy T, Voeltzke K, Hruby L, Alasad K, Bas Z, Snaebjörnsson M, et al.. mTORC1 regulates cell survival under glucose starvation through 4EBP1/2-mediated translational reprogramming of fatty acid metabolism. . 2024. PMID 38744825 · DOI · PMC11094136
  2. Yi Y, Wang G, Zhang W, Yu S, Fei J, An T, et al.. Mitochondrial-cytochrome c oxidase II promotes glutaminolysis to sustain tumor cell survival upon glucose deprivation. . 2025. PMID 39747079 · DOI · PMC11695821
  3. Zheng X, Liu J, Hu W, Jiang B, Zhou X, Zhang M, et al.. Curcumin Induces Autophagy-mediated Ferroptosis by Targeting the PI3K/AKT/mTOR Signaling Pathway in Gastric Cancer. . 2024. PMID 39150386 · DOI · PMC11363205
  4. Sravya K, Rao A, Harshitha P, Parithathvi A, Dsouza HS. Characterizing the molecular mechanisms underlying aluminium-induced disruptions in neuronal survival pathways. . 2026. PMID 42658284 · DOI · PMC13522080
  5. Parzych KR, Klionsky DJ. An overview of autophagy: morphology, mechanism, and regulation. Antioxid Redox Signal. 2014. PMID 23725295 · DOI · PMC3894687
  6. Gottesman MM. Mechanisms of cancer drug resistance. Annu Rev Med. 2002. PMID 11818492 · DOI
  7. Cory S, Huang DC, Adams JM. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene. 2003. PMID 14634621 · DOI
  8. Kruiswijk F, Labuschagne CF, Vousden KH. p53 in survival, death and metabolic health: a lifeguard with a licence to kill. Nat Rev Mol Cell Biol. 2015. PMID 26122615 · DOI
  9. Codogno P, Meijer AJ. Autophagy and signaling: their role in cell survival and cell death. Cell Death Differ. 2005. PMID 16247498 · DOI
  10. Rampersad SN. Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays. Sensors (Basel). 2012. PMID 23112716 · DOI · PMC3478843

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-29.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • Cell DeathMolecular Biology
  • Cell DifferentiationMolecular Biology
  • Cell FusionMolecular Biology
  • Cell PolarityMolecular Biology
  • ExocytosisMolecular Biology
  • Disease-Free SurvivalClinical Research

All 100 articles in Molecular Biology →

At a glance

237,115
PubMed records on this heading
17%
published since 2020
8,750
review articles
238
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-29; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • Cell DeathMolecular Biology
  • Cell DifferentiationMolecular Biology
  • Cell FusionMolecular Biology
  • Cell PolarityMolecular Biology
  • ExocytosisMolecular Biology

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support